PBMs and insurers want your prescription money
World of DTC Marketing
JULY 27, 2022
anti-kickback law that the drugmaker said prevented it from helping heart failure patients, many with low incomes, afford the medicine that costs $225,000 annually. Pharma companies have very little control over patients’ prices for their Rxs. A federal appeals court rejected Pfizer’s challenge to a U.S.
Let's personalize your content